論文 (2007年)

  • Yan HT, Shinka T, Sato Y, Yang XJ, Chen G, Sakamoto K, Kinoshita K, Aburatani H, Nakahori Y. Overexpression of SOX15 Inhibits Proliferation of NT2/D1 Cells Derived from a Testicular Embryonal Cell Carcinoma. Mol Cells. 24(3):323-8. 2007
  • Yamamoto Y, Uehara A, Miura K, Watanabe A, Aburatani H, Komiyama M. Development of Artificial Restriction DNA Cutter Composed of Ce(Iv)/EDTA and PNA. Nucleosides Nucleotides Nucleic Acids. 26(10):1265-8. 2007
  • Nakamura Y, Matsubara D, Goto A, Ota S, Sachiko O, Ishikawa S, Aburatani H, Miyazawa K, Fukayama M, Niki T.  Constitutive activation of c-Met is correlated with c-Met overexpression and dependent on cell-matrix adhesion in lung adenocarcinoma cell lines. Cancer Sci. 99(1):14-22. 2008.
  • Hayashi M, Maeda S, Aburatani H, Kitamura K, Miyoshi H, Miyazono K, Imamura T. Pitx2 prevents osteoblastic trans-differentiation of myoblasts by bone morphogenetic proteins. J Biol Chem. 283(1):565-71. 2008.
  • Ehata S, Hanyu A, Hayashi M, Aburatani H, Kato Y, Fujime M, Saitoh M, Miyazawa K, Imamura T, Miyazono K. Transforming Growth Factor-{beta} Promotes Survival of Mammary Carcinoma Cells through Induction of Antiapoptotic Transcription Factor DEC1. Cancer Res.67(20):9694-703. 2007
  • Yoneda M, Endo H, Nozaki Y, Tomimoto A, Fujisawa T, Fujita K, Yoneda K, Takahashi H, Saito S, Iwasaki T, Yamamoto S, Tsutsumi S, Aburatani H, Wada K, Hotta K, Nakajima A. Life Style-Related Diseases of the Digestive System: Gene Expression in Nonalcoholic Steatohepatitis Patients and Treatment Strategies. J Pharmacol Sci. 2007 Oct 6; [Epub ahead of print]
  • Morikawa T, Sugiyama A, Kume H, Ota S, Kashima T, Tomita K, Kitamura T, Kodama T, Fukayama M, Aburatani H. Identification of toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin Cancer Res. 13(19):5703-9. 2007
  • Kimura M, Yamamoto T, Zhang J, Itoh K, Kyo M, Kamiya T, Aburatani H, Katsuoka F, Kurokawa H, Tanaka T, Motohashi H, Yamamoto M. Molecular basis distinguishing the DNA binding profile of NRF2-MAF heterodimer from that of MAF homodimer. J Biol Chem. 2007 Sep 17; [Epub ahead of print]
  • Inaki M, Yoshikawa S, Thomas JB, Aburatani H, Nose A. Wnt4 Is a Local Repulsive Cue that Determines Synaptic Target Specificity. Curr Biol. 17(18):1574-9. 2007
  • Fujii K, Ishikawa S, Uchikawa H, Komura D, Shapero MH, Shen F, Hung J, Arai H, Tanaka Y, Sasaki K, Kohno Y, Yamada M, Jones KW, Aburatani H, Miyashita T. High-density oligonucleotide array with sub-kilobase resolution reveals breakpoint information of submicroscopic deletions in nevoid basal cell carcinoma syndrome. Hum Genet. 2007 Aug 17; [Epub ahead of print]
  • Lu Y, Kitaura J, Oki T, Komeno Y, Ozaki K, Kiyono M, Kumagai H, Nakajima H, Nosaka T, Aburatani H, Kitamura T. Identification of TSC-22 as a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD. Leukemia. 2007 Aug 9; [Epub ahead of print]
  • Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara SI, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 448(7153):561-6. 2007
  • Futagami Y, Sugita S, Vega J, Ishida K, Takase H, Maruyama K, Aburatani H, Mochizuki M. Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells. J Immunol.178(11):6994-7005. 2007
  • Murata K, Ota S, Niki T, Goto A, Li CP, Ruriko UM, Ishikawa S, Aburatani H, Kuriyama T, Fukayama M. p63 – Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis. Exp Mol Pathol. 2007 Apr 10; [Epub ahead of print]
  • Narumiya H, Hidaka K, Shirai M, Terami H, Aburatani H, Morisaki T. Endocardiogenesis in embryoid bodies: Novel markers identified by gene expression profiling. Biochem Biophys Res Commun. 357(4):896-902. 2007
  • Yoshitake H, Takahashi M, Ishikawa H, Nojima M, Iwanari H, Watanabe A, Aburatani H, Yoshida K, Ishi K, Takamori K, Ogawa H, Hamakubo T, Kodama T, Araki Y. Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int J Gynecol Cancer. 2007 Apr 9; [Epub ahead of print]
  • Wang T, Niki T, Goto A, Ota S, Morikawa T, Nakamura Y, Ohara E, Ishikawa S, Aburatani H, Nakajima J, Fukayama M. Hypoxia increases the motility of lung adenocarcinoma cell line A549 via activation of the epidermal growth factor receptor pathway. Cancer Sci. 98(4):506-11. 2007
  • Osaka N, Takahashi T, Murakami S, Matsuzawa A, Noguchi T, Fujiwara T, Aburatani H, Moriyama K, Takeda K, Ichijo H. ASK1-dependent recruitment and activation of macrophages induce hair growth in skin wounds. J Cell Biol. 176(7):903-909. 2007
  • Takayama K, Kaneshiro K, Tsutsumi S, Horie-Inoue K, Ikeda K, Urano T, Ijichi N, Ouchi Y, Shirahige K, Aburatani H, Inoue S. Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis.Oncogene. 2007 Feb 5; [Epub ahead of print]
  • Yoshizumi S, Suzuki S, Hirai M, Hinokio Y, Yamada T, Yamada T, Tsunoda U, Aburatani H, Yamaguchi K, Miyagi T, Oka Y. Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice. Metabolism. 56(3):420-9. 2007
  • Terami H, Hidaka K, Shirai M, Narumiya H, Kuroyanagi T, Arai Y, Aburatani H, Morisaki T. Efficient capture of cardiogenesis-associated genes expressed in ES cells. Biochem Biophys Res Commun. 355(1):47-53. 2007 [Epub 2007 Jan 30].
  • Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM Jr, Azuma T, Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007 Jan 22; [Epub ahead of print]
  • Tonami K, Kurihara Y, Aburatani H, Uchijima Y, Asano T, Kurihara H. Calpain 6 Is Involved in Microtubule Stabilization and Cytoskeletal Organization. Mol Cell Biol. 27(7):2548-61. 2007 [Epub 2007 Jan 8]
  • Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest.117(1):246-257. 2007